By Dr Didu Sanduni Thamarasa Kariyawasam

Reports

Kariyawasam D; Farrar M; Meagher C; Heather N; Bhattacharya K; Sampaio H; Cini J; Masi E; Burrows L; Greenslade M; Heller R; Allcock R; Divanisova S; Carrivick S; Kay A; Siu C; Webster D; Ranieri E; Moore F; Crisp G; Pitt J; Greed L; De Hora M; Greaves R; Wotton T; Wilgen U; Wiley V; Cairns A; Clark D; Yiu E; O'Grady G; Kava M; Ware T; Miller C; Tolich F; Wedlake C, 2025, A Guideline for Newborn Screening in Spinal Muscular Atrophy in Australia and Aotearoa New Zealand, University of New South Wales, http://dx.doi.org/10.26190/unsworks/31305, https://www.unsw.edu.au/content/dam/images/medicine-health/clinical-medicine/research/2025-05-nbs-for-sma/2025-05-nba-for-sma-guideline-280525.pdf

Preprints

D'Silva AM; Sampaio H; Kariyawasam DST; Mowat D; Russell J; Junek Z; Jones KJ; Alexander IE; Best S; Wiley V; Farrar MA, 2021, Integrating a Pilot Newborn Screening for Spinal Muscular Atrophy Into the Australian Public Healthcare System, http://dx.doi.org/10.2139/ssrn.3814778

Kariyawasam DST; D'Silva AM; Vetsch J; Wakefield C; Wiley V; Farrar MA, 2020, 'We Needed This': Perspectives of Parents and Healthcare Professionals Involved in a Pilot Newborn Screening Program for Spinal Muscular Atrophy, http://dx.doi.org/10.2139/ssrn.3682109

Kariyawasam D; Scarfe J; Meagher C; Farrar MA; Bhattacharya K; Carter SM; Newson AJ; Otlowski M; Watson J; Millis N; Norris S, Genetic newborn screening stakeholder perspectives, http://dx.doi.org/10.1101/2024.02.11.24302654

Back to profile page